HFS
ATOS icon

Hantz Financial Services’s Atossa Therapeutics ATOS Stock Holding History

Hantz Financial Services’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed – – 2456
2025
Q4 		$0 Hold
5
– – ﹤0.01% 2409
2025
Q3 		$0 Hold
5
– – ﹤0.01% 2322
2025
Q2 		$0 Hold
5
– – ﹤0.01% 2182
2025
Q1 		$0 Hold
5
– – ﹤0.01% 1684
2024
Q4 		$0 Hold
5
– – ﹤0.01% 1091
2024
Q3 		$0 Hold
5
– – ﹤0.01% 1071
2024
Q2 		$0 Hold
5
– – ﹤0.01% 1066
2024
Q1 		$0 Hold
5
– – ﹤0.01% 1194
2023
Q4 		$0 Hold
5
– – ﹤0.01% 1123
2023
Q3 		$0 Hold
5
– – ﹤0.01% 1115
2023
Q2 		$0 Hold
5
– – ﹤0.01% 1080
2023
Q1 		$0 Hold
5
– – ﹤0.01% 1107
2022
Q4 		$0 Hold
5
– – ﹤0.01% 1076
2022
Q3 		$0 Hold
5
– – ﹤0.01% 1069
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1039
2022
Q1 		$0 Buy
+5
New +$102 ﹤0.01% 1020

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hantz Financial Services's ATOS Position: Q1 2026 in Review

Hantz Financial Services sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 5 shares.

Hantz Financial Services first reported a position in ATOS in Q1 2022 and held it in 16 quarters. The position peaked at $0 in Q4 2025. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • Hantz Financial Services reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Hantz Financial Services sold 5 Atossa Therapeutics shares in Q1 2026.
  • Hantz Financial Services first reported a position in Atossa Therapeutics in Q1 2022 and held it in 16 quarters.
  • Hantz Financial Services's Atossa Therapeutics position peaked at $0 in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.